Selegiline Hydrochloride Market

Selegiline Hydrochloride is the hydrochloride salt form of selegiline, a levorotatory acetylenic derivative of phenethylamine with antiparkinsonian effect. As a selective monoamine oxidase (MAO) inhibitor, selegiline has the greatest affinity for type B MAO, found mainly in the brain. Selegiline is converted by MAO B to an active moiety, which binds irreversibly at the active site of the enzyme's cofactor FAD (flavin adenine dinucleotide) molecule. This prevents the oxidative deamination of catecholamines and serotonin by MAO B, and leads to an increase in these neurotransmitters' activities resulting in improved motor function. In addition, this agent may inhibit re-uptake of dopamine by the neuron and prolong dopamine activity.
Selegiline Hydrochloride Market contains market size and forecasts of Selegiline Hydrochloride in global, including the following market information:
Global Selegiline Hydrochloride Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Selegiline Hydrochloride Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Selegiline Hydrochloride companies in 2021 (%)
The global Selegiline Hydrochloride market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Tablet Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Selegiline Hydrochloride include Somerset Pharmaceuticals Inc., Mylan Specialty, Draxis Health Inc., Deprenyl Research Ltd., Golden State Medical Supply, Mayne Pharma, Endo Pharmaceuticals, Par Pharmaceutical and Apotex Corp. and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Selegiline Hydrochloride manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Selegiline Hydrochloride Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Selegiline Hydrochloride Market Segment Percentages, by Type, 2021 (%)
Tablet
Capsule
Global Selegiline Hydrochloride Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Selegiline Hydrochloride Market Segment Percentages, by Application, 2021 (%)
Parkinson's disease
Depression
Global Selegiline Hydrochloride Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Selegiline Hydrochloride Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Selegiline Hydrochloride revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Selegiline Hydrochloride revenues share in global market, 2021 (%)
Key companies Selegiline Hydrochloride sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Selegiline Hydrochloride sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Somerset Pharmaceuticals Inc.
Mylan Specialty
Draxis Health Inc.
Deprenyl Research Ltd.
Golden State Medical Supply
Mayne Pharma
Endo Pharmaceuticals
Par Pharmaceutical
Apotex Corp.
A-S Medication Solutions